Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study.
Mylene BassalMariana SilvaSerina PatelPaul J GibsonVicky R BreakeyUma H AthaleVeda ZabihQing LiPetros PechlivanoglouJason D PoleNicole MittmannRinku SutradharSumit GuptaPublished in: Pediatric blood & cancer (2021)
These results can be used to inform anticipatory guidance for families, particularly those undergoing intensified therapy. Our results also suggest that increased toxicity rates associated with dexamethasone during Induction seen in clinical trials reflect real-world practice.
Keyphrases
- acute lymphoblastic leukemia
- clinical trial
- healthcare
- emergency department
- primary care
- young adults
- public health
- palliative care
- oxidative stress
- allogeneic hematopoietic stem cell transplantation
- stem cells
- randomized controlled trial
- combination therapy
- risk assessment
- quality improvement
- study protocol
- replacement therapy
- open label
- cell therapy
- double blind
- phase iii